Hygieia Biological Laboratories
PrivateLast Round
Series B
May 2, 2023
Total Funding Raised
$5.28M
Company Overview
Hygieia Biological Laboratories is a biotechnology company that researches, develops, and manufactures innovative veterinary and human vaccines and pharmaceuticals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hygieia Biological Laboratories Comparables
Compare Hygieia Biological Laboratories with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vacci-Vet Inc. | 86% | |
| Medgene Labs | 85% | |
| Cambridge Technologies | 84% |
Hygieia Biological Laboratories Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 2, 2023 | ||||
| Grant | Sep 3, 2020 |
Hygieia Biological Laboratories Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Russell L. Rustici Rangeland & Cattle Research Endowment | Grant |
| University of California | Grant |
| Firstime | Series B |
| GlenRock Israel | Series B |
| Livestock Memorial Research Fund | Grant |
| UC Davis Department of Animal Science | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors grew 160% MoM to 1.3K.
Hygieia Biological Laboratories Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access